← Back to Search

Endoscopy for Stomach Cancer Detection and Prevention

N/A

Recruiting

Led By Haejin In, MD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from the time of consent to through five calendar days after screening/treatment

Awards & highlights

Study Summary

This trial provides three distinct opportunities to decrease gastric cancer (GC) morbidity and mortality. It has potential to discover cancer in early stages before the onset of symptoms, leading to higher rates of survival. Second, premalignant lesions such as adenomatous polyps, intestinal metaplasia and dysplasia can be discovered and removed with local resection, akin to polypectomies during screening colonoscopies, preventing the development of cancer. Third, EGD discovery and treatment of active Helicobacter pylori (HP) infection of the stomach provides an opportunity for primary prevention of GC.

Who is the study for?

This trial is for individuals aged between 40 and 80 who haven't had an esophagogastroduodenoscopy (EGD) in the last five years. It's especially aimed at those at high risk of stomach cancer, willing to follow the study rules, and planning to have a colonoscopy. People with conditions that make EGD risky or previous stomach surgery are excluded.Check my eligibility

What is being tested?

The pilot study tests whether early detection and prevention of stomach cancer can be achieved through EGD screening. The procedure may identify early-stage cancers, remove precancerous growths like polyps, and treat Helicobacter pylori infections to prevent future cancer development.See study design

What are the potential side effects?

While not detailed here, typical side effects from an EGD might include sore throat, bloating, mild cramping or discomfort; more serious but rare risks involve bleeding or perforation of the stomach lining.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre-study screening day -30 to day 0

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre-study screening day -30 to day 0

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-study screening day -30 to day 0 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Number of participants with AE's will be measured by the Cancer Therapy Evaluation Program Common Toxicity Criteria (CTC) Version 5.0

Other outcome measures

Esophagogastroduodenoscopy

Trial Design

1Treatment groups

Experimental Treatment

Group I: EGD at time of routine screening colonoscopyExperimental Treatment1 Intervention

This happens on Day 0. Screening for EGD, biopsy samples from esophagus, stomach, gastrointestinal junction, and duodenum AE's.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

64,182 Total Patients Enrolled

Haejin In, MDPrincipal InvestigatorRutgers Cancer Institute of New Jersey

Media Library

esophagogastroduodenoscopy (EGD) Clinical Trial Eligibility Overview. Trial Name: NCT05566899 — N/A

Stomach Cancer Research Study Groups: EGD at time of routine screening colonoscopy

Stomach Cancer Clinical Trial 2023: esophagogastroduodenoscopy (EGD) Highlights & Side Effects. Trial Name: NCT05566899 — N/A

esophagogastroduodenoscopy (EGD) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05566899 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial include elderly participants?

"The requirements for entry into this clinical trial are that applicants be between 40-80 years old. There is a separate cohort of 20 trials available to those under 18, while 624 studies are open to individuals over 65."

Answered by AI

Are there any opportunities available to patients who are interested in participating in this investigation?

"Per clinicaltrials.gov, this medical trial is no longer actively seeking participants; the study was first posted on December 1st 2022 and last updated on October 2nd 2022. Despite not being available for enrollment anymore, there are currently 630 other studies recruiting patients."

Answered by AI

Is there an opportunity for me to join this research project?

"This clinical trial is seeking 50 individuals aged 40 to 80 with a malignant stomach neoplasm. Participants must meet the stipulated criteria: sign and provide informed consent, not have had an EGD in the past 5 years, willing to participate in all protocol aspects, be from high-risk groups (for half of participants), and able to undergo colonoscopy."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy

Haejin In 2023. "Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05566899.

All > No Stomach For Cancer